SBB-32265-30048
3 vaccinations
4 coded responses
37 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 480 / MI
- Registered
- 2021-04-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-21
Registered in v-safe
-
2021-04-21
Dose 1 — Pfizer-BioNTech
-
2021-04-21
Survey response — day 0, dose 1MedDRA: Dizziness, Vertigo — Feeling: Fair · Site: PainFree text: Slight dizziness and transient vertigoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-22
- 2021-04-23
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-04-28
- 2021-05-06
-
2021-05-12
Dose 2 — Pfizer-BioNTech
- 2021-05-12
-
2021-05-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-05-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-05-15
- 2021-05-16
- 2021-05-17
- 2021-05-18
- 2021-05-19
- 2021-05-26
- 2021-06-02
- 2021-06-09
- 2021-06-16
-
2021-06-23
Survey response — day 42, dose 2MedDRA: Arthralgia, Decreased appetite, Headache, Nausea, Taste disorder — Feeling: Good · Be unable to do your normal daily activitiesFree text: Nausea, headache, joint pain for about a day; loss of appetite for 1 day, taste changes since then (2 days)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-08-11
- 2021-11-11
-
2022-01-16
Dose 3 — Pfizer-BioNTech
-
2022-01-17
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-01-19
- 2022-01-20
- 2022-01-21
- 2022-01-23
-
2022-01-30
Survey response — day 14, dose 3MedDRA: Fatigue, Nasopharyngitis — Feeling: FairFree text: Cold symptoms and fatigueMedDRA releases: 2024-11 · check-in free text available
- 2022-02-06
- 2022-02-13
- 2022-02-20
- 2022-02-27
- 2022-04-17
-
2022-07-17
Survey response — 6 months, dose 3MedDRA: Oropharyngeal pain — Feeling: GoodFree text: Had a sore throat for a week.MedDRA releases: 2024-11 · check-in free text available
- 2023-01-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-21 | Pfizer-BioNTech | |
| 2 | 2021-05-12 | Pfizer-BioNTech | |
| 3 | 2022-01-16 | Pfizer-BioNTech | No |
Free text
Release 7 — day 0, dose 1
Systemic reaction (other): Slight dizziness and transient vertigo
Release 9 — day 42, dose 2
Symptoms: Nausea, headache, joint pain for about a day; loss of appetite for 1 day, taste changes since then (2 days)
Release 11 — day 14, dose 3
Symptoms: Cold symptoms and fatigue
Release 12 — 6 months, dose 3
Symptoms: Had a sore throat for a week.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Decreased appetite | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Taste disorder | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Vertigo | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release